Combo Boosts Breast Cancer Survival in BOLERO-2

feeds has 409 videos Subscribe Here

Description: Combined treatment with everolimus and exemestane more than doubled median progression-free survival in postmenopausal women with hormone receptor-positive breast cancer that had advanced previously after hormone therapy. Dr. Gabriel N. Hortobagyi discusses the results of the BOLERO-2 trial. See the related story at
Shared By : feeds
Posted on : 12/10/11
Added : 6 years ago
Category : Breast Cancer

More From feeds

Nothing found.